...
search icon
hae-img

Haemonetics Corporation, Common Stock

HAE

NYQ

$67.99

+$1.93

(2.92%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$3.31B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
19.9577
Volume info-icon
This is the total number of shares traded during the most recent trading day.
532.53K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.32
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$55.3 L
$94.98 H
$67.99

About Haemonetics Corporation, Common Stock

Haemonetics Corporation, a medical technology company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 tool. It also provides treatment in electrophysiology, critical care, neurocritical care, trauma, burn surgery, spine surgery, and cancer surgery, among others; SavvyWire, a sensor-guided 3-in-1 guidewire for TAVR procedures; and OptoWire, a pressure guidewire that measures fractional flow reserve and diastolic pressure ratio, as well as fiber optic sensor solutions used in medical devices and other critical industrial applications. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE closure products comprising VASCADE 5F, VASCADE 6/7F, VASCADE MVP XL, and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, clinical specialists, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameHAESectorS&P500
1-Week Return-1.34%-3.24%-2.29%
1-Month Return8.54%-5.96%5.13%
3-Month Return5.3%-11.47%-1.04%
6-Month Return-22.64%-11.3%-3.3%
1-Year Return-23.57%-8.64%9.3%
3-Year Return5.97%-2.75%39.44%
5-Year Return-37.8%29.73%90.79%
10-Year Return63.48%73.6%173.11%

Financials

Mar '21Mar '22Mar '23Mar '24Mar '255YR TREND
Total Revenue870.46M993.20M1.17B1.31B1.36B[{"date":"2021-03-31","value":63.97,"profit":true},{"date":"2022-03-31","value":72.98,"profit":true},{"date":"2023-03-31","value":85.88,"profit":true},{"date":"2024-03-31","value":96.2,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Cost of Revenue472.63M487.69M553.56M617.51M611.87M[{"date":"2021-03-31","value":76.54,"profit":true},{"date":"2022-03-31","value":78.98,"profit":true},{"date":"2023-03-31","value":89.64,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":99.09,"profit":true}]
Gross Profit397.84M505.50M615.10M691.55M748.96M[{"date":"2021-03-31","value":53.12,"profit":true},{"date":"2022-03-31","value":67.49,"profit":true},{"date":"2023-03-31","value":82.13,"profit":true},{"date":"2024-03-31","value":92.33,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Gross Margin45.70%50.90%52.63%52.83%55.04%[{"date":"2021-03-31","value":83.04,"profit":true},{"date":"2022-03-31","value":92.48,"profit":true},{"date":"2023-03-31","value":95.63,"profit":true},{"date":"2024-03-31","value":95.99,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Operating Expenses339.88M433.78M459.06M526.66M527.14M[{"date":"2021-03-31","value":64.48,"profit":true},{"date":"2022-03-31","value":82.29,"profit":true},{"date":"2023-03-31","value":87.09,"profit":true},{"date":"2024-03-31","value":99.91,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Operating Income57.96M80.75M156.03M164.88M221.82M[{"date":"2021-03-31","value":26.13,"profit":true},{"date":"2022-03-31","value":36.4,"profit":true},{"date":"2023-03-31","value":70.34,"profit":true},{"date":"2024-03-31","value":74.33,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(1.88M)(34.24M)(29.26M)(67.99M)(19.49M)[{"date":"2021-03-31","value":-188400000,"profit":false},{"date":"2022-03-31","value":-3424200000,"profit":false},{"date":"2023-03-31","value":-2926000000,"profit":false},{"date":"2024-03-31","value":-6799000000,"profit":false},{"date":"2025-03-31","value":-1949200000,"profit":false}]
Pre-Tax Income72.91M63.63M141.40M151.87M212.07M[{"date":"2021-03-31","value":34.38,"profit":true},{"date":"2022-03-31","value":30,"profit":true},{"date":"2023-03-31","value":66.68,"profit":true},{"date":"2024-03-31","value":71.61,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Income Taxes(6.56M)20.25M26.00M34.31M44.39M[{"date":"2021-03-31","value":-14.77,"profit":false},{"date":"2022-03-31","value":45.63,"profit":true},{"date":"2023-03-31","value":58.57,"profit":true},{"date":"2024-03-31","value":77.28,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Income After Taxes79.47M43.38M115.40M117.56M167.68M[{"date":"2021-03-31","value":47.39,"profit":true},{"date":"2022-03-31","value":25.87,"profit":true},{"date":"2023-03-31","value":68.82,"profit":true},{"date":"2024-03-31","value":70.11,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Income From Continuous Operations79.47M43.38M115.40M117.56M-[{"date":"2021-03-31","value":67.6,"profit":true},{"date":"2022-03-31","value":36.9,"profit":true},{"date":"2023-03-31","value":98.17,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Income From Discontinued Operations-----[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Net Income79.47M43.38M115.40M117.56M167.68M[{"date":"2021-03-31","value":47.39,"profit":true},{"date":"2022-03-31","value":25.87,"profit":true},{"date":"2023-03-31","value":68.82,"profit":true},{"date":"2024-03-31","value":70.11,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
EPS (Diluted)2.352.593.033.984.57[{"date":"2021-03-31","value":51.42,"profit":true},{"date":"2022-03-31","value":56.67,"profit":true},{"date":"2023-03-31","value":66.3,"profit":true},{"date":"2024-03-31","value":87.09,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

HAE
Cash Ratio 0.53
Current Ratio 1.62
Quick Ratio 0.99

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

HAE
ROA (LTM) 6.65%
ROE (LTM) 18.83%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

HAE
Debt Ratio Lower is generally better. Negative is bad. 0.61
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.39

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

HAE
Trailing PE 19.96
Forward PE 13.64
P/S (TTM) 2.33
P/B 3.87
Price/FCF 31
EV/R 3.01
EV/Ebitda 12.13
PEG 1.14

FAQs

What is Haemonetics Corporation share price today?

Haemonetics Corporation (HAE) share price today is $67.99

Can Indians buy Haemonetics Corporation shares?

Yes, Indians can buy shares of Haemonetics Corporation (HAE) on Vested. To buy Haemonetics Corporation from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in HAE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Haemonetics Corporation be purchased?

Yes, you can purchase fractional shares of Haemonetics Corporation (HAE) via the Vested app. You can start investing in Haemonetics Corporation (HAE) with a minimum investment of $1.

How to invest in Haemonetics Corporation shares from India?

You can invest in shares of Haemonetics Corporation (HAE) via Vested in three simple steps:

  • Click on Sign Up or Invest in HAE stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Haemonetics Corporation shares
What is Haemonetics Corporation 52-week high and low stock price?

The 52-week high price of Haemonetics Corporation (HAE) is $94.98. The 52-week low price of Haemonetics Corporation (HAE) is $55.3.

What is Haemonetics Corporation price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Haemonetics Corporation (HAE) is 19.9577

What is Haemonetics Corporation price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Haemonetics Corporation (HAE) is 3.87

What is the Market Cap of Haemonetics Corporation?

The market capitalization of Haemonetics Corporation (HAE) is $3.31B

What is Haemonetics Corporation’s stock symbol?

The stock symbol (or ticker) of Haemonetics Corporation is HAE

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top